DeepCell

Where AI meets living cells

San Francisco Bay Area, United States · Founded 2017 · $20.0M raised

Employees
51–200
Founded
2017
Business Model
B2B
Total Funding
$20.0M
Last Round
$20.0M Series ADec 2020
Rounds
1

About

DeepCell is a life sciences technology company that has developed the REM-I platform — an integrated system combining label-free imaging, deep learning AI, and gentle cell enrichment to analyze and sort living cells based on their morphology. The platform enables researchers and clinicians to profile single cells without fluorescent labels or destructive preparation, revealing high-dimensional biological insights invisible to conventional methods. Key application areas include oncology (tumor heterogeneity, rare cell sorting), drug discovery (phenotypic screening, mechanism of action), and cell and gene therapy (quality control, manufacturing). DeepCell is headquartered in Menlo Park, California.

Summary

DeepCell is an Artificial Intelligence company based in San Francisco Bay Area, United States, founded in 2017. It has raised $20.0M in total across 1 round, most recently a $20.0M Series A round in Dec 2020. Investors include Bow Capital and Andreessen Horowitz.

Tech & App Stack

6 technologies & apps tracked

Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series ASeries ADec 2020
$20.0M

Investors

Similar Companies